This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbosa-de-Deus, R.
Right arrow Articles by Tavares, C. A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbosa-de-Deus, R.
Right arrow Articles by Tavares, C. A. P.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, November 2002, p. 1361-1366, Vol. 9, No. 6
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.6.1361-1366.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Leishmania major-Like Antigen for Specific and Sensitive Serodiagnosis of Human and Canine Visceral Leishmaniasis

Rosângela Barbosa-de-Deus,1 Marcos Luíz dos Mares-Guia,2 Adriane Zacarias Nunes,3 Kátia Morais Costa,2 Roberto Gonçalves Junqueira,4 Wilson Mayrink,5 Odair Genaro,5 and Carlos Alberto Pereira Tavares2*

Departamento de Farmácia, UFOP,1 Departamento de Bioquímica-Imunologia,2 Departamento de Parasitologia, Instituto de Ciências Biológicas,5 Departamento de Alimentos, Faculdade de Farmácia, Universidade Federal de Minas Gerais,4 Fundação Ezequiel Dias, Minas Gerais, Brazil3

Received 12 February 2002/ Returned for modification 17 May 2002/ Accepted 19 August 2002

An antigen (LMS) prepared from Leishmania major-like promastigotes was used in an enzyme-linked immunosorbent assay (ELISA) for the diagnosis of human and dog visceral leishmaniasis. The results were compared with those from the indirect immunofluorescent antibody test (IFAT). A total of 1,822 canine sera were tested, including sera from dogs with visceral leishmaniasis, transmissible venereal tumors, ehrlichiosis, rickettsiosis, or Chagas' disease and sera from healthy dogs. The antigen was also tested with 227 samples of human sera, including sera from patients with visceral, cutaneous, or diffuse cutaneous leishmaniasis and from noninfected individuals, as well as sera from patients with Chagas' disease, toxoplasmosis, rickettsiosis, hepatitis B, schistosomiasis, ascaridiasis, malaria, rheumatoid factor, leprosy and rheumatoid factor, tuberculosis, or leprosy. All dogs and all human patients had a clinical and/or serological and/or parasitological diagnosis. For detecting antibodies in sera from dogs with leishmaniasis, the antigen showed a sensitivity of 98%, specificity of 95%, and concordance of 93% and when used for detecting antibodies in human sera presented a sensitivity of 92%, specificity of 100%, and concordance of 92%. Comparison between ELISA and IFAT demonstrated that ELISA using the LMS antigen yielded more reliable results than IFAT. The LMS antigen displayed no cross-reactivity with sera from patients or dogs that had any of the other diseases tested.

* Corresponding author. Mailing address: Departamento de Bioquímica-Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, P.O. Box 486, 30161-970, Belo Horizonte, Minas Gerais, Brazil. Phone: 55 31 3499 2526. Fax: 55 31 34415963. E-mail: capt{at}icb.ufmg.br.

Clinical and Diagnostic Laboratory Immunology, November 2002, p. 1361-1366, Vol. 9, No. 6
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.6.1361-1366.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»